Igor Vorozhtsov, M.D. Email & Phone Number

Russia

Moscow, Russia

From the industry leading Motiva® implants and Mia® femtech to cutting-edge innovations in hemostasis and wound healing — we’re pioneering the world's breakthrough solutions in aesthetic medicine across & beyond the Eurasian Economic Union, leveraging our stellar medical education & commercial infrastructure.

• Global expansion, in/out-licensing, orphan portfolio & pipeline development with its consequent commercialization
• Identified, negotiated and executed several licensing and exclusive distribution deals across the US, Europe, MENA, LATAM, and APAC worth $50m+
• Full P&L responsibility for Specialty & Rare Diseases BU with a cross-functional team incl. dedicated Sales & Marketing, Medical Affairs, Value Demonstration & Access, in close collaboration with Regulatory Affairs.

Moscow, Russian Federation

• P&L responsibility for a $20m diverse portfolio and team of 65 FTEs, incl. Sales & Marketing, Value Demonstration & Access, and Business Development across 3 merged BUs
• Achieved sales targets and expanded funding across the board, with Ozurdex HTL inclusion and Botox Tx DRG breakthrough

Moscow, Russian Federation

• Built a commercial organization of 32 FTEs from the ground up, incl. successful Baxalta integration, retaining the entire team:- developed 6 team members into Sales Management and Marketing roles, incl. 2 international.
• Full P&L responsibility for a $0.3m ➝ $30m portfolio of 13 products, incl. 6 launches across 8 therapeutic areas:- consistently exceeded performance objectives and sales targets despite inherited stock, Gx pressure or.
• Led the country Business Development and key strategic innovation projects:- pioneered the Named Patient Access (import before registration) with the first Revestive ultra-rare patients ever funded across Eurasia.

Moscow, Russian Federation

• Established Internal Medicine & Gastrointestinal BU with 5 new products, incl. 4 launches - each business case endorsed at the ILT and ExCo levels
• Doubled Shire’s margin by negotiating & executing repatriation of several products from J&J
• Expanded existing and set new distribution contracts, along with two localization projects

Moscow, Russian Federation

• $40m GI portfolio development, incl. a PPI blockbuster revival
• «Best Marketer 2013-2014», «Gold Encore Award» for Pariet rebranding with an authentic integrated campaign driving double-digit Rx growth

Moscow, Russian Federation

• Launched two innovative GI products from scratch: “Encore Award” for the best launch NPS and top-of-mind awareness in the segment
• Built lasting relations with the national GI community, as well as global KOLs in Neurogastromotility and Inflammatory Bowel Diseases

Moscow, Russian Federation

Pre-launch of two innovative GI products

Düsseldorf Area, Germany

Tel-Aviv, Israel

Greater Boston Area

Doctor Of Medicine - Md, Distinction

Activities and Societies: President of the Student Scientific SocietyWinner of State grant for postgraduate study in the UK

Master Of Science - Ms, International Management, Distinction

Activities and Societies: Saatchi & Saatchi London ScholarshipDissertation: "Effective pharmaceutical marketing communications"